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Expression of calcyclin in different cell lines and mouse tissues was determined with polyclonal antibodies raised against 
calcyclin from Ehrlich ascites tumour (EAT) cells. The protein was detected in mouse skeletal and cardiac muscle, in 
lung, kidney and spleen, and was especially enriched in mouse smooth muscle as well as in rat fibroblasts. No positive 
immunological reaction was detected in mouse brain, liver and intestine and some tumourigenic ell lines. The level of 
calcyclin mRNA found in different cells and tissues corresponded well to the calcyclin level estimated by immunoblotting. 
The calcyclin-like protein was purified from mouse stomach and appeared to be very similar to the EAT protein. 
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1. INTRODUCTION 
We have purified to homogeneity a 10.5 kDa 
calcium-binding protein from Ehrlich ascites 
tumour (EAT) cells [l], which, on the basis of se- 
quence homologies was called calcyclin-like protein 
(Kuinicki, Filipek, Hunziker, Huber and Heiz- 
mann, submitted). Originally, calcyclin was a term 
given to the hypothetical product of a gene (2A9), 
transcription of which was found inducible by 
growth factors [2,3]. It has been suggested that 
calcyclin is involved in the regulation of cell pro- 
liferation and, on the basis of its deduced amino 
acid sequence, that it binds calcium [2,3]. To reveal 
more information about possible functions of 
calcyclin we searched for it in a variety of mouse 
tissues as well as in different cell lines using anti- 
bodies raised against he EAT protein. In addition, 
we purified the calcyclin-like protein from smooth 
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muscle and compared some of its properties with 
those of the EAT protein. 
2. MATERIALS AND METHODS 
2.1. Proteins 
Calcyclin was isolated from Ehrlich ascites tumour cells as 
described earlier [l]. Calcium-binding protein from mouse 
stomach was purified using the same method. The protein con- 
centration was estimated according to Bradford’s procedure 
(BioRad) with bovine y-globulin as a standard. 
2.2. Cells 
PtKz cells (kidney epithelial cells from rat kangaroo) and rat 
fibroblasts were grown on coverslips in minimal essential 
medium (MEM) (Gibco, Scotland) supplemented with 7% fetal 
calf serum (FCS) (Gibco). V2 (rabbit carcinoma) cells were 
grown in MEM, 15% FCS and Ag8 cells in RPM1 1640 (Gibco), 
10% FCS. 
2.3. Tissue and cell extracts 
Three volumes of deionized water were added to the pellet of 
cultured cells (previously washed with phosphate buffered 
saline) or to the mouse tissues and the suspensions were 
homogenized using tissue grind glass-glass homogenizer (B. 
Braun, Melsungen). To all extracts, 2 mM DTE, 2 mM EGTA 
and 0.5 mM PMSF was added. The extracts were centrifuged in 
an Eppendorf centrifuge for 10 min and the supernatants were 
collected. 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/89/$3.50 0 1989 Federation of European Biochemical Societies 141 
Volume 254, number 1,2 FEBS LETTERS August 1989 
2.4. Antibodies 
The polyclonal antibodies were raised in a female SPF bastard 
rabbit by injecting 1 mg of purified calcyclin from EAT cells 
with complete Freund’s adjuvant and, after four weeks 1 mg 
calcyclin emulsified in incomplete Freund’s adjuvant. Serum 
was collected one week after the second injection and antibodies 
against calcyclin were purified by affinity chromatography. 
2.5. Gel analysis and immunoblotting 
Tissue and cell extracts were subjected to one- or two- 
dimensional polyacrylamide gel electrophoresis [4,5]. In the lat- 
ter case, proteins were first separated on the isoelectrofocusing 
gels in pH 3.5-10 ampholines (LKB Instrument GmbH, Grafel- 
fing, FRG) in capillaries 1 .l mm diameter, and the second 
dimension was run on 12.5% polyacrylamide minislabs in the 
presence of SDS. Polyacrylamide gel electrophoresis in the 
presence of 6 M urea was performed according to Drabikowski 
et al. [6]. Gels were stained with Coomassie brillant blue. Im- 
munoreactivity was analysed by blotting the proteins from the 
polyacrylamide gels onto nitrocellulose sheets [7]. The blots 
were allowed to react with anti-calcyclin followed by sheep-anti- 
rabbit IgG conjugated with horseradish peroxidase (Nordic, 
Tilburg, The Netherlands). Staining was developed with chloro- 
naphthol and HrOz [8]. 
2.6. RNA isolation, electrophoresis and hybridization 
Total RNA was extracted from cells and tissues as in 191. Elec- 
trophoresis of cellular RNA, blotting onto nitrocellulose and 
hybridization with full-length human calcyclin gene (2A9) were 
performed as in [2,3]. 
2.7, Light and electron microscopy 
Mouse skeletal muscle (m. vastus from a 2-month-old NMRI 
mouse) was fixed in Bouin fixative, embedded in paraffin, sec- 
tioned (8 pm) and dewaxed. Sections were incubated with 
calcyclin antibody, washed and subsequently reacted with the 
second antibody coupled to horseradish peroxidase (HRP). Col- 
our development was performed with diaminobenzidine and the 
samples were flat-embedded in araldite resin, photographed, 
ultra-thin sectioned, poststained with uranyl acetate and lead 
citrate, and inspected with a Zeiss EM 109 electron microscope. 
3. RESULTS AND DISCUSSION 
3.1. Tissue specific distribution of calcyclin 
On two-dimensional blots, derived from low 
ionic strength extracts of EAT cells, polyclonal an- 
tibody raised against .EAT cells calcyclin reacted 
only with one protein spot. The spot was cor- 
responding to the monomer of calcyclin (fig.1). 
The antibody recognized a calcyclin-like polypep- 
tide in immunoblots of a variety of cells and mouse 
tissues (fig.2). The strongest reaction was observed 
in mouse stomach and in rat fibroblasts. In spleen, 
lung and kidney the major staining was observed 
with a polypeptide at the level of 25 kDa, but a 
weak reaction with a 10.5 kDa band was also seen. 
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Fig.1. Protein blot analysis using calcyclin antibodies. Low 
ionic strength extracts of EAT cells were separated electro- 
phoretically on two-dimensional gels. Proteins were transferred 
to nitrocellulose and the blots were incubated with anti- 
calcyclin. Immunoreaction was visualized by incubation with 
peroxidase-coupled sheep anti-rabbit IgG. 
The double band of 10.5 kDa protein in the extract 
of skeletal muscle was not seen in other ex- 
periments. No positive immunological reaction 
with calcyclin antibody was observed in extracts 
from brain (fig.2), intestine and liver (not shown). 
The antibody against calcyclin from EAT cells fail- 
ed to detect any protein in PtKz cells, Ag8 cells and 
V2 rabbit carcinoma cells (not shown). Antibody 
against calcyclin from EAT cells did not react with 
other calcium-binding proteins such as calmodulin, 
parvalbumin, S-100 and oncomodulin (not shown). 
3.2. Purification of calcyclin-like protein from 
mouse stomach 
The calcium-binding protein was purified from 
mouse stomach using the procedure developed for 
EAT calcyclin. This indicates that the smooth mus- 
cle protein has chemical and physical properties 
similar to calcyclin from EAT cells. Moreover, 
both proteins behaved identically on SDS-PAGE 
and on urea-PAGE (in the presence and absence of 
calcium ions), as seen in fig.3, and on two- 
dimensional gels (not shown). This indicates that 
they are very similar (if not identical) with respect 
to their molecular weight, charge and 
Ca’+-induced conformational states. 
3.3. Northern blot analysis of calcyclin mRNA 
levels 
Fig.4 presents a Northern blot analysis of 
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Fig.2. Immunoblot analysis of the tissue distribution of 
calcyclin. The low ionic strength extracts of different mouse 
tissues and of rat fibroblasts were separated on SDS gel, blotted 
to nitrocellulose and stained with Ponceau red (upper part), and 
anti-calcyclin (lower part). Lanes: 1, lung; 2, kidney; 3, spleen; 
4, heart; 5, brain; 6, skeletal muscle; 7, stomach; 8, rat fibro- 
blasts; 9, EAT calcyclin. 
calcyclin mRNA levels in EAT cells as well as in 
different organs of the mouse. The highest level of 
calcyclin mRNA was observed in EAT cells and a 
much weaker signal was detected in RNA isolated 
from stomach. No signal was observed in RNA 
isolated from liver, brain, kidney, skeletal muscle 
and spleen. This tissue distribution of calcyclin 
mRNA is in good agreement with our data on pro- 
tein distribution and it can be taken as further 
proof of the identity of calcyclin with the 10.5 kDa 
calcium-binding protein from EAT cells. 
3.4. Immunocytochemistry 
Cross sections of mouse skeletal muscle after in- 
cubation with calcyclin antibodies were inspected 
in the light and electron microscope (fig.5). It was 
found that in skeletal muscle of mouse only fibro- 
blasts were stained, but not the muscle fibers. 
Fig.3. Autoradiogram of Northern blot demonstrating different 
levels of calcyclin mRNA in mouse tissues. Total RNA isolated 
from cells and tissues was labeled with 3zP-calcyclin probe. 
Lanes: 1, liver; 2, EAT cells; 3, brain; 4, muscle (m. vastus); 5, 
stomach; 6, kidney; 7, spleen. 
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Fig.4. Electrophoretic omparison of calcyclin from EAT cells 
(1) and a protein from mouse stomach (2). The samples contain- 
ed either 0.1 mM CaClr (+) or 1 mM EGTA (-). (A) 15% 
PAGE in the presence of SDS; (B) 8% PAGE in the presence of 
urea. 
3.5. Conclusions 
Calcyclin is a member of the S-100 protein fami- 
ly [lo]. It binds calcium and zinc ions and both ca- 
tions may regulate its possible involvement in the 
control of cell proliferation activity (Filipek, Heiz- 
mann and Kuinicki, unpublished). The data of this 
work show that calcyclin is not a tumour specific 
protein, and that in normal tissues it seems to be 
expressed in cells capable of proliferation. 
143 
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Fig.5. Localization of calcyclin in mouse skeletal muscle. (A,B) Light micrograph; (C) electron micrograph. A and B, Dark HRP- 
product shows that calcyclin is localized within triangular shaped cells situated between the muscle fibers (M). P, perimysium. C, elec- 
tron microscopy shows that calcyclin is present within the cytoplasm of fibroblasts excluding the endoplasmic reticulum (ER). N, 
nucleus. Bar: A,B, 20 pm; C, 2 pm. 
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